Literature DB >> 10329448

Direct visualization of HIV-1 entry: mechanisms and role of cell surface receptors.

R H Stauber1, S Rulong, G Palm, N I Tarasova.   

Abstract

Highly fluorescent virions of T- and M-tropic HIV-1 strains were obtained by incorporation of the viral accessory protein Vpr, fused to the green fluorescent protein, in trans. The fluorescent virions displayed normal morphology, were infectious, and could be used for direct visualization of HIV-1 attachment and trafficking in various cell lines. More than 90% of the viral particles were found to enter the cells by direct membrane fusion in T-cells, CD4+ HeLa cells, and macrophages. Visualizing HIV-1 attachment and entry in the absence or presence of CD4 and/or the appropriate coreceptors indicated that CD4 is the major receptor for virus attachment in the case of JR-CSF and NL-4-3 HIV-1 isolates; however, the coreceptors are required for membrane fusion. Internalization of the coreceptor CXCR4 inhibited entry, but did not prevent virus binding suggesting that transient downregulation of the coreceptor(s) may not be the most efficient way of blocking HIV infection in vivo. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329448     DOI: 10.1006/bbrc.1999.0511

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.

Authors:  E Schaeffer; R Geleziunas; W C Greene
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag).

Authors:  Y Jenkins; O Pornillos; R L Rich; D G Myszka; W I Sundquist; M H Malim
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  Fluorescently-labeled RNA packaging into HIV-1 particles: Direct examination of infectivity across central nervous system cell types.

Authors:  Ruqiang Xu; Nazira El-Hage; Seth M Dever
Journal:  J Virol Methods       Date:  2015-08-10       Impact factor: 2.014

4.  Proteolytic cleavage of HIV-1 GFP-Vpr fusions at novel sites within virions and living cells: concerns for intracellular trafficking studies.

Authors:  Leon Caly; David A Jans; Sabine C Piller
Journal:  J Fluoresc       Date:  2008-12-07       Impact factor: 2.217

5.  Human retinal microglia express candidate receptors for HIV-1 infection.

Authors:  V T Pham; L Wen; P McCluskey; M C Madigan; P L Penfold
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

6.  Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactions.

Authors:  Hans J Kueng; Calin Manta; Daniela Haiderer; Victoria M Leb; Klaus G Schmetterer; Alina Neunkirchner; Ruth A Byrne; Clemens Scheinecker; Peter Steinberger; Brian Seed; Winfried F Pickl
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

7.  Fluorescent protein-tagged Vpr dissociates from HIV-1 core after viral fusion and rapidly enters the cell nucleus.

Authors:  Tanay M Desai; Mariana Marin; Chetan Sood; Jiong Shi; Fatima Nawaz; Christopher Aiken; Gregory B Melikyan
Journal:  Retrovirology       Date:  2015-10-29       Impact factor: 4.602

8.  Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles.

Authors:  Jerlisa Ann C Arizala; Mayumi Takahashi; John C Burnett; Dominique L Ouellet; Haitang Li; John J Rossi
Journal:  AIDS Res Hum Retroviruses       Date:  2018-07-05       Impact factor: 2.205

9.  Functional incorporation of green fluorescent protein into hepatitis B virus envelope particles.

Authors:  Carsten Lambert; Nicole Thomé; Christoph J Kluck; Reinhild Prange
Journal:  Virology       Date:  2004-12-05       Impact factor: 3.616

Review 10.  Imaging Viral Infection by Fluorescence Microscopy: Focus on HIV-1 Early Stage.

Authors:  Soumajit Mukherjee; Emmanuel Boutant; Eleonore Réal; Yves Mély; Halina Anton
Journal:  Viruses       Date:  2021-01-30       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.